U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H24O7
Molecular Weight 376.4004
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SERGLIFLOZIN

SMILES

COC1=CC=C(CC2=C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=CC=C2)C=C1

InChI

InChIKey=HFLCZNNDZKKXCS-OUUBHVDSSA-N
InChI=1S/C20H24O7/c1-25-14-8-6-12(7-9-14)10-13-4-2-3-5-15(13)26-20-19(24)18(23)17(22)16(11-21)27-20/h2-9,16-24H,10-11H2,1H3/t16-,17-,18+,19-,20-/m1/s1

HIDE SMILES / InChI

Molecular Formula C20H24O7
Molecular Weight 376.4004
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 08:53:15 UTC 2023
Edited
by admin
on Sat Dec 16 08:53:15 UTC 2023
Record UNII
AR34521QFL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SERGLIFLOZIN
WHO-DD  
Common Name English
Sergliflozin [WHO-DD]
Common Name English
.BETA.-D-GLUCOPYRANOSIDE, 2-((4-METHOXYPHENYL)METHYL)PHENYL
Systematic Name English
SERGLIFLOZIN A
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID00189662
Created by admin on Sat Dec 16 08:53:15 UTC 2023 , Edited by admin on Sat Dec 16 08:53:15 UTC 2023
PRIMARY
CAS
360775-96-8
Created by admin on Sat Dec 16 08:53:15 UTC 2023 , Edited by admin on Sat Dec 16 08:53:15 UTC 2023
PRIMARY
SMS_ID
300000042190
Created by admin on Sat Dec 16 08:53:15 UTC 2023 , Edited by admin on Sat Dec 16 08:53:15 UTC 2023
PRIMARY
FDA UNII
AR34521QFL
Created by admin on Sat Dec 16 08:53:15 UTC 2023 , Edited by admin on Sat Dec 16 08:53:15 UTC 2023
PRIMARY
WIKIPEDIA
Sergliflozin
Created by admin on Sat Dec 16 08:53:15 UTC 2023 , Edited by admin on Sat Dec 16 08:53:15 UTC 2023
PRIMARY
PUBCHEM
10177526
Created by admin on Sat Dec 16 08:53:15 UTC 2023 , Edited by admin on Sat Dec 16 08:53:15 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY